Aller au contenu

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), Spanish Group for Research on Sarcomas (GEIS)

Nom du journal : Ann Oncol

Année : 2021

Volume : 32

Page de départ : 533

Page de fin : 541

Auteurs: Velasco AP, Zalcberg JR, Broto JM, Kotasek D, Fumagalli E, Gelderblom H, Gronchi A, Rutkowski P, Litière S, Hartmann JT, Wardelmann E, Marréaud S, Italiano A, Duffaud F, Judson IR, Hohenberger P, Casali PG, Goldstein D, Penel N, Blay JY, Le Cesne A,